Scribe Therapeutics

Scribe Therapeutics company information, Employees & Contact Information

Scribe is enabling the creation of genetic medicines through its CRISPR by Design™ approach to genetic modification.

Company Details

Employees
112
Address
1150 Marina Village Pkwy, Alameda,ca 94501,united States
Email
bd****@****etx.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Alameda, CA
Looking for a particular Scribe Therapeutics employee's phone or email?

Scribe Therapeutics Questions

News

Press Release Service: Scribe Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference - CRISPR Medicine News

Press Release Service: Scribe Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference CRISPR Medicine News

Scribe Therapeutics Reports Positive Preclinical Data on its Novel CRISPR Technologies at the 2025 EAS Congress and ASGCT Annual Meeting - Yahoo Finance

Scribe Therapeutics Reports Positive Preclinical Data on its Novel CRISPR Technologies at the 2025 EAS Congress and ASGCT Annual Meeting Yahoo Finance

Scribe Therapeutics Achieves Milestone for In Vivo Program in Collaboration with Sanofi - Business Wire

Scribe Therapeutics Achieves Milestone for In Vivo Program in Collaboration with Sanofi Business Wire

Press Release Service: Scribe Achieves Milestone for In Vivo Program in Collaboration with Prevail Therapeutics, a part of Lilly’s Gene Therapy Division, and Announces ASGCT Joint Presentation on Self-Inactivating AAV Technology for Neurological and Ne - CRISPR Medicine News

Press Release Service: Scribe Achieves Milestone for In Vivo Program in Collaboration with Prevail Therapeutics, a part of Lilly’s Gene Therapy Division, and Announces ASGCT Joint Presentation on Self-Inactivating AAV Technology for Neurological and Ne CRISPR Medicine News

Scribe Announces Collaboration with Prevail, a Wholly Owned Subsidiary of Lilly, to Accelerate In Vivo CRISPR-based Genetic Medicines for Neurological and Neuromuscular Diseases - Business Wire

Scribe Announces Collaboration with Prevail, a Wholly Owned Subsidiary of Lilly, to Accelerate In Vivo CRISPR-based Genetic Medicines for Neurological and Neuromuscular Diseases Business Wire

Press Release Service: Scribe Therapeutics to Participate in Upcoming Conferences - CRISPR Medicine - CRISPR Medicine News

Press Release Service: Scribe Therapeutics to Participate in Upcoming Conferences - CRISPR Medicine CRISPR Medicine News

Scribe Therapeutics Expands In Vivo Collaboration with Sanofi to Second Target - Business Wire

Scribe Therapeutics Expands In Vivo Collaboration with Sanofi to Second Target Business Wire

Press Release Service: Scribe Therapeutics Presents Data on its X-Editing Technologies at 2023 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting - CRISPR Medicine News

Press Release Service: Scribe Therapeutics Presents Data on its X-Editing Technologies at 2023 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting CRISPR Medicine News

Scribe Therapeutics Announces Expansion of San Francisco Bay Area Headquarters, 3 Key Senior Hires - Business Wire

Scribe Therapeutics Announces Expansion of San Francisco Bay Area Headquarters, 3 Key Senior Hires Business Wire

Scribe Therapeutics Announces Research Collaboration with Sanofi to Accelerate Breakthrough CRISPR-based Cell Therapies for Cancer - Business Wire

Scribe Therapeutics Announces Research Collaboration with Sanofi to Accelerate Breakthrough CRISPR-based Cell Therapies for Cancer Business Wire

Top Scribe Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant